Target intelligence / Profile preview

Denatured/necrotic tissue proteins

Molecular classification
Protein, Other
01

Overview

Denatured and necrotic tissue proteins consist of non-viable proteinaceous matter, such as collagen, fibrin, and elastin, that accumulates in wounds following cell death and extracellular matrix degradation (StatPearls, "Wound Debridement", 2023). This material, often manifesting as eschar or slough, acts as a mechanical barrier to wound healing, prevents the formation of granulation tissue, and provides a substrate for microbial colonization (Wound Repair and Regeneration, 2014). In clinical practice, these proteins are the primary target for enzymatic debridement agents, which are topically applied proteolytic enzymes designed to selectively break down the chemical bonds of devitalized tissue (FDA, Santyl Label). By degrading these proteins, the drugs facilitate the removal of necrotic debris, reduce the inflammatory load, and promote the transition of the wound into a proliferative healing phase (Journal of Burn Care & Research, 2021). This therapeutic approach is particularly vital in the management of severe burns and chronic, non-healing ulcers where surgical debridement may be contraindicated or insufficient.

Other names
Necrotic debrisDevitalized tissueEscharSloughNon-viable tissue proteins
02

Mechanism of action

Enzymatic proteolysis and hydrolysis of peptide bonds within non-viable tissue to facilitate debridement.

03

Biological functions

Cell deathImmune responseOther
04

Disease associations

InfectionOther
05

Safety considerations

Proteolysis of healthy viable tissueLocal irritationHypersensitivityPain at the application site
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Wound bed appearancePresence of escharPresence of sloughWound bed color (black/yellow)

Beyond the preview

Go deeper on Denatured/necrotic tissue proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denatured/necrotic tissue proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call